Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies

被引:87
|
作者
Chen, Wensen [1 ,2 ]
Wang, Sumin [3 ]
Tian, Tian [1 ]
Bai, Jianling [1 ]
Hu, Zhibin [1 ]
Xu, Yan [1 ]
Dong, Jing [1 ]
Chen, Feng [1 ]
Wang, Xinru [1 ]
Shen, Hongbing [1 ]
机构
[1] Nanjing Med Univ, Ctr Canc, Lab Reprod Med, Nanjing 210029, Peoples R China
[2] Jiangsu Prov Ctr Dis Prevent & Control, Sect Disinfect & Vector Control, Nanjing, Peoples R China
[3] Nanjing Med Univ, Nanjing Matern & Child Hlth Hosp, Nanjing 210029, Peoples R China
关键词
IGF1; IGFBP3; polymorphism; cancer risk; meta-analysis; LIFE-STYLE FACTORS; BREAST-CANCER; FACTOR-I; PROSTATE-CANCER; CIRCULATING LEVELS; COLORECTAL-CANCER; FACTOR (IGF)-I; SERUM-LEVELS; PROMOTER POLYMORPHISM; REPEAT POLYMORPHISMS;
D O I
10.1038/ejhg.2009.86
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin-like growth factor 1 (IGF1) and its main binding protein, IGF-binding protein 3 (IGFBP3), play an important role in cancer development. Circulating levels and functional polymorphisms of IGF1 and IGFBP3 may be biomarkers of cancer development. However, the results of published studies remain conflicting rather than conclusive. We searched MEDLINE and EMBASE databases for all published studies related to circulating levels and polymorphisms of IGF1 and IGFBP3 and cancer risk. In all, 96 studies and over 110 000 subjects were available for this meta-analysis. Higher IGF1 circulating levels significantly increased 15% of cancer risk (odds ratio (OR), 1.15, 95% confidence interval (CI), 1.03-1.29), especially among prostate, pre-menopausal breast and colorectal cancer patients, whereas higher concentrations of IGFBP3 significantly decreased the risk of advanced prostate cancer by 56% (OR, 0.44, 95% CI, 0.25-0.77). Meanwhile, IGFBP3 -202CC genotype was associated with an increased risk of prostate cancer with borderline significance (OR, 1.18, 95% CI, 0.99-1.41). Genotype-phenotype correlation analyses showed that circulating levels of IGFBP3 could be modified by its promoter polymorphism A-202C (P<0.001). In conclusion, circulating levels of IGF1, IGFBP3 and IGFBP3 A-202C play a crucial role in carcinogenesis and could serve as susceptibility biomarkers for cancer development. European Journal of Human Genetics (2009) 17, 1668-1675; doi:10.1038/ejhg.2009.86; published online 3 June 2009
引用
收藏
页码:1668 / 1675
页数:8
相关论文
共 50 条
  • [41] Reduced serum insulin-like growth factor (IGF) and IGF-binding protein-3 concentrations in two deerhounds with congenital portosystemic shunts
    Maxwell, A
    Hurley, K
    Burton, C
    Batt, R
    Camacho-Hübner, C
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2000, 14 (05) : 542 - 545
  • [42] Prognostic Role of Plasma Insulin-Like Growth Factor (IGF) and IGF-Binding Protein 3 in Metastatic Colorectal Cancer
    Garcia-Albeniz, Xabier
    Gallego, Rosa
    CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5288 - 5288
  • [43] Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density
    Byrne, C
    Colditz, GA
    Willett, WC
    Speizer, FE
    Pollak, M
    Hankinson, SE
    CANCER RESEARCH, 2000, 60 (14) : 3744 - 3748
  • [44] Usefullness of Serum Insulin-Like Growth Factor (IGF-1) and Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) for Colorectal Cancer Diagnosis
    Yilmazi, Oemer
    Koruk, Irfan
    Cayir, Kerim
    Koruk, Mehmet
    Yilmaz, Arif
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2009, 19 (01): : 23 - 27
  • [45] Serum insulin-like growth factor (IGF)-1 and IGF-binding protein-3 do not correlate with adverse pathological features in prostate cancer patients undergoing biopsy
    Ismail, HR
    Behlouli, H
    Tanguay, S
    Bégin, L
    Pollak, M
    Aprikian, A
    JOURNAL OF UROLOGY, 2002, 167 (04): : 287 - 287
  • [46] Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease
    Katsanos, KH
    Tsatsoulis, A
    Christodoulou, D
    Challa, A
    Katsaraki, A
    Tsianos, EV
    GROWTH HORMONE & IGF RESEARCH, 2001, 11 (06) : 364 - 367
  • [47] Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: Therapeutic efficacy and mechanism of protection against type 1 diabetes
    Chen, W
    Salojin, KV
    Mi, QS
    Grattan, M
    Meagher, TC
    Zucker, P
    Delovitch, TL
    ENDOCRINOLOGY, 2004, 145 (02) : 627 - 638
  • [48] Behcet's syndrome and relationship with the ratio of insulin-like growth factor-1 (IGF-1)/IGF-binding protein-3 (IGFBP-3)
    Dogan, Ozlem
    Unal, Emine
    Kisa, Ucler
    Aksoy, Nurkan
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2019, 36 (03): : 295 - 301
  • [49] Measurement of Insulin-like Growth Factor (IGF)-1 and IGF-Binding Protein 3 in Pediatric Multiple Sclerosis Patients
    Gombolay, Grace Y.
    Saxena, Shrishti
    Keyhanian, Kiandokht
    Gonzalez, Cindy T.
    Misra, Madhusmita
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 12 - 13
  • [50] Insulin-like growth factor-I (IGF-1), IGF-binding protein-3 (GFBP-3), and mammographic breast density.
    Diorio, C
    Pollak, M
    Byrne, C
    Mâsse, B
    Côté, G
    Hébert-Croteau, N
    Yaffe, M
    Bérubé, S
    Morin, C
    Brisson, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 835S - 835S